共 23 条
[1]
Messiou C(2018)Whole-body imaging in multiple myeloma Magn Reson Imaging Clin N Am 26 509-525
[2]
Kaiser M(2015)Assessing myeloma bone disease with whole-body diffusion-weighted imaging: comparison with x-ray skeletal survey by region and relationship with laboratory estimates of disease burden Clin Radiol 70 614-621
[3]
Giles SL(2016)Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma? Leukemia 30 1446-1448
[4]
Pawlyn C(2017)Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma Blood 130 30-34
[5]
Rasche L(2015)Whole body diffusion weighted MRI--a new view of myeloma Br J Haematol 171 29-37
[6]
Messiou C(2015)Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement J Clin Oncol 33 657-664
[7]
Kaiser M(2010)Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma J Clin Oncol 28 1606-1610
[8]
Dimopoulos MA(2014)Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma Leukemia 28 1902-1908
[9]
Hillengass J(2013)Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease Leukemia 27 947-953
[10]
Merz M(2013)Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma N Engl J Med 369 438-447